TOBCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。TOB遺伝子サイレンサーは、TOB CRISPR/Cas9ノックアウトプラスミドとTOBDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のTOBCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
TOB CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
TOB1 CRISPR/Cas9 KOプラスミド (h) | sc-402842 | h | Gene Knockout | GFP | 0 | ||
TOB1 HDRプラスミド (h) | sc-402842-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TOB1 Double Nickaseプラスミド (h) | sc-402842-NIC | h | Gene Knockout | Puromycin | 0 | ||
TOB1 Double Nickaseプラスミド (h2) | sc-402842-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TOB1 CRISPR/Cas9 KOプラスミド (m) | sc-423508 | m | Gene Knockout | GFP | 0 | ||
TOB1 HDRプラスミド (m2) | sc-423508-HDR-2 | m | Homology Directed Repair | Puromycin | 0 | ||
TOB1 Double Nickaseプラスミド (m) | sc-423508-NIC | m | Gene Knockout | Puromycin | 0 | ||
TOB1 Double Nickaseプラスミド (m2) | sc-423508-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TOB2 CRISPR/Cas9 KOプラスミド (h) | sc-404242 | h | Gene Knockout | GFP | 0 | ||
TOB2 HDRプラスミド (h) | sc-404242-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TOB2 Double Nickaseプラスミド (h) | sc-404242-NIC | h | Gene Knockout | Puromycin | 0 | ||
TOB2 Double Nickaseプラスミド (h2) | sc-404242-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TOB2 CRISPR/Cas9 KOプラスミド (m) | sc-425354 | m | Gene Knockout | GFP | 0 | ||
TOB2 HDRプラスミド (m) | sc-425354-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TOB2 Double Nickaseプラスミド (m) | sc-425354-NIC | m | Gene Knockout | Puromycin | 0 | ||
TOB2 Double Nickaseプラスミド (m2) | sc-425354-NIC-2 | m | Gene Knockout | Puromycin | 0 |
TOB CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
TOB1 CRISPR Activationプラスミド (h) | sc-402842-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB1 CRISPR Activationプラスミド (h2) | sc-402842-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB1 Lentiviral Activation Particles (h) | sc-402842-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB1 Lentiviral Activation Particles (h2) | sc-402842-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB1 CRISPR Activationプラスミド (m) | sc-423508-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB1 CRISPR Activationプラスミド (m2) | sc-423508-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB1 Lentiviral Activation Particles (m) | sc-423508-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB1 Lentiviral Activation Particles (m2) | sc-423508-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB2 CRISPR Activationプラスミド (h) | sc-404242-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB2 CRISPR Activationプラスミド (h2) | sc-404242-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB2 Lentiviral Activation Particles (h) | sc-404242-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB2 Lentiviral Activation Particles (h2) | sc-404242-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB2 CRISPR Activationプラスミド (m) | sc-425354-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB2 CRISPR Activationプラスミド (m2) | sc-425354-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB2 Lentiviral Activation Particles (m) | sc-425354-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TOB2 Lentiviral Activation Particles (m2) | sc-425354-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |